Food-Responsive Dermatosis in Dogs: Nutritional Evidence and Diagnostic Diets
VetFarmacy Clinical Evidence Library
Body System: Integumentary (Dermatology)
Author: Dr. Athena Angela Gaffud
Content Type: Condition Evidence Overview
Evidence Base: Peer-reviewed veterinary and translational literature synthesis
Last Reviewed: 2026
Purpose: Evidence-based synthesis of current veterinary and translational literature evaluating the role of nutrition in food-responsive dermatosis, elimination diets, and dietary hypersensitivity in dogs
Evidence Transparency
This article synthesizes evidence from veterinary dermatology, clinical nutrition, immunology, gastroenterology, and microbiome research to explain how nutrition influences food-responsive dermatosis (FRD) in dogs. Priority is given to controlled veterinary clinical trials, systematic reviews, consensus recommendations, and mechanistic studies evaluating dietary interventions for cutaneous adverse food reactions (CAFR). Human and laboratory animal studies are included only where they provide biologically plausible mechanisms that have not yet been fully investigated in dogs.
Evidence is clearly distinguished according to its strength:
-
Strong evidence: Supported by veterinary clinical trials, elimination diet studies, or consensus guidelines.
-
Emerging evidence: Supported by recent clinical trials, microbiome research, or early nutritional intervention studies requiring further validation.
-
Extrapolated evidence: Derived from mechanistic studies, experimental models, or human dermatology literature and interpreted cautiously for canine patients.
This content is intended for educational purposes to support evidence-informed nutritional decision-making. It does not replace individualized veterinary diagnosis or treatment.
Introduction
Food-responsive dermatosis (FRD) is a clinical syndrome in which dermatologic signs improve or resolve following elimination of dietary allergens and recur after dietary provocation. It represents the cutaneous manifestation of cutaneous adverse food reactions (CAFR) and differs from environmental allergic diseases in that nutrition serves not only as supportive therapy but also as the primary diagnostic tool.
Unlike many chronic dermatologic disorders, the diagnosis of FRD depends on a carefully designed elimination diet followed by a controlled dietary challenge rather than on laboratory testing alone. Consequently, nutritional management occupies a unique role in veterinary dermatology: the selected diet simultaneously serves as both a diagnostic intervention and a therapeutic strategy.
Although food-responsive dermatosis accounts for only a subset of canine allergic skin disease, it is an important differential diagnosis in dogs presenting with non-seasonal pruritus, recurrent otitis externa, superficial pyoderma, or concurrent gastrointestinal signs. Failure to recognize dietary triggers often leads to prolonged symptomatic treatment without addressing the underlying immune response.
Emerging research also demonstrates that food-responsive skin disease extends beyond simple reactions to dietary proteins. Alterations in intestinal barrier integrity, microbial ecology, immune tolerance, epithelial lipid metabolism, and systemic inflammatory signaling collectively influence disease expression, highlighting the importance of the gut–skin axis in canine dermatology (Watson, 1998).
This article examines food-responsive dermatosis through a mechanism-first nutritional framework, emphasizing how dietary composition influences immune regulation, skin barrier function, and clinical outcomes. For a broader overview of nutritional approaches to dermatologic disease, see Nutritional Management of Canine Skin Health: Evidence Overview.
Readers seeking background on nutrition-related inflammatory mechanisms may also find the VetFarmacy Evidence Library topic Gut Microbiome and Digestive Health useful.
Pathophysiology of Food-Responsive Dermatosis
Food-responsive dermatosis develops through complex interactions among dietary antigens, gastrointestinal immune regulation, epithelial barrier integrity, and cutaneous inflammatory responses. Rather than representing a single disease process, FRD reflects failure of normal oral immune tolerance, allowing dietary proteins to trigger chronic immune activation in genetically susceptible dogs.
Loss of Oral Tolerance and Immune Dysregulation
Claim: Food-responsive dermatosis begins with disruption of oral immune tolerance toward dietary antigens.
Mechanism: Under physiological conditions, intestinal dendritic cells promote differentiation of regulatory T cells (Tregs), suppressing unnecessary immune responses against dietary proteins. Breakdown of this tolerance permits inappropriate activation of helper T lymphocytes, cytokine production, and allergen-specific inflammatory pathways that ultimately affect both gastrointestinal and cutaneous tissues.
Persistent exposure to offending dietary proteins perpetuates cytokine signaling involving interleukins such as IL-4, IL-13, and IL-31, contributing to pruritus, epidermal inflammation, and recruitment of inflammatory cells.
Clinical relevance: Successful elimination diets remove the antigenic stimulus responsible for immune activation rather than merely suppressing downstream inflammation. This explains why nutritional intervention remains the diagnostic gold standard for suspected food-responsive dermatosis (Olivry et al., 2010; Eisenschenk, 2024).
Strong evidence: Controlled elimination diet trials consistently demonstrate clinical improvement following removal of offending dietary antigens.
Gastrointestinal Barrier Dysfunction and the Gut–Skin Axis
Claim: Altered intestinal barrier function contributes to systemic immune activation in food-responsive dermatosis.
Mechanism: Tight junction disruption increases intestinal permeability, allowing greater translocation of dietary antigens and microbial products across the intestinal epithelium. This stimulates mucosal immune cells, enhances antigen presentation, and promotes chronic inflammatory signaling that extends beyond the gastrointestinal tract.
Changes in the intestinal microbiome further influence immune homeostasis through microbial metabolites, including short-chain fatty acids, which regulate epithelial integrity and regulatory T-cell function.
Clinical relevance: Nutritional strategies that improve gastrointestinal barrier integrity may reduce antigen exposure and help restore immune tolerance, providing a mechanistic rationale for elimination diets and microbiome-directed nutritional interventions.
Emerging evidence: Recent dietary intervention studies demonstrate improvements in both skin disease and microbial diversity following nutritional modulation (Guidi et al., 2021; Badri et al., 2024; Lagoa et al., 2025).
Epidermal Barrier Dysfunction and Lipid Abnormalities
Claim: Skin barrier impairment amplifies inflammatory responses in food-responsive dermatosis.
Mechanism: The canine epidermis depends on an organized extracellular lipid matrix composed primarily of ceramides, cholesterol, and free fatty acids. Inflammatory cytokines alter lipid synthesis and keratinocyte differentiation, increasing transepidermal water loss (TEWL) and facilitating penetration of environmental allergens, microbes, and irritants.
Deficiencies in epidermal lipids perpetuate inflammation by creating a cycle of barrier disruption and immune activation.
Clinical relevance: Nutritional interventions that support epidermal lipid metabolism may complement elimination diets by enhancing barrier repair following antigen removal.
Emerging evidence: Experimental and clinical studies indicate that dietary omega-3 fatty acids influence epidermal lipid composition, and that ceramide-related pathways are promising therapeutic targets (Popa et al., 2011; Yoon et al., 2020; Marsella, 2013).
Inflammatory Lipid Mediators
Claim: Dietary fatty acid composition influences inflammatory signaling associated with food-responsive dermatosis.
Mechanism: Omega-6 fatty acids serve as precursors for numerous pro-inflammatory lipid mediators, whereas long-chain omega-3 fatty acids compete for the same enzymatic pathways, shifting production toward less inflammatory eicosanoids and specialized pro-resolving mediators.
The relative balance between dietary omega-6 and omega-3 fatty acids therefore influences cytokine production, leukocyte recruitment, and inflammatory resolution.
Clinical relevance: Appropriate fatty acid balance may reduce the intensity of pruritus and inflammatory skin lesions when used alongside elimination diets, rather than as a replacement for diagnostic dietary trials.
Strong evidence: Multiple veterinary clinical trials demonstrate improvements in clinical scores with therapeutic diets enriched in essential fatty acids, although responses vary among individuals (Abbà et al., 2005; Bensignor et al., 2008; Saevik et al., 2004).
Oxidative Stress and Cellular Injury
Claim: Oxidative stress contributes to persistent inflammation and delayed barrier recovery.
Mechanism: Chronic inflammatory activation generates reactive oxygen species (ROS), damaging keratinocyte membranes, proteins, and intracellular signaling pathways. Oxidative injury also impairs epidermal repair, disrupts lipid synthesis, and amplifies inflammatory cytokine production.
Persistent oxidative stress may therefore sustain clinical disease despite removal of dietary allergens if barrier recovery remains incomplete.
Clinical relevance: Nutritional strategies that support antioxidant defenses may complement broader dietary management by reducing secondary cellular injury.
Emerging evidence: Functional diets incorporating antioxidant nutrients have demonstrated improvements in dermatologic scores and inflammatory biomarkers in recent clinical investigations, although additional controlled studies remain necessary (Badri & Panickar, 2022; De Santiago et al., 2021).
Nutritional Risk Factors
Nutrition does not independently cause food-responsive dermatosis, but dietary composition influences immune activation, intestinal barrier integrity, and inflammatory responses that determine whether susceptible dogs develop clinical disease.
Protein Antigen Exposure
Claim: Dietary proteins represent the primary nutritional trigger for food-responsive dermatosis.
Mechanism: Intact dietary proteins capable of crossing a compromised intestinal barrier may be recognized as foreign antigens, initiating adaptive immune responses that perpetuate cutaneous inflammation. Repeated exposure to previously sensitizing proteins increases the likelihood of recurrent clinical signs.
Clinical relevance: Identification and removal of the offending protein remain the cornerstone of nutritional diagnosis.
Macronutrient Quality and Digestibility
Claim: Nutrient digestibility influences gastrointestinal antigen exposure and immune stimulation.
Mechanism: Highly digestible diets reduce the amount of undigested substrate reaching the distal intestine, potentially limiting microbial dysbiosis and the production of inflammatory metabolites. In contrast, poorly digestible ingredients may increase luminal fermentation, alter microbial composition, and compromise epithelial integrity.
Clinical relevance: Digestibility represents an important consideration when selecting diets for elimination trials or long-term management.
Readers interested in nutrient utilization and gastrointestinal absorption can explore:
Nutrient Bioavailability and Digestibility in Dogs: Clinical Implications for Diet Selection
Fat Composition
Claim: Dietary lipid composition influences inflammatory responses independently of total fat intake.
Mechanism: Imbalances in omega-6 and omega-3 fatty acids alter production of inflammatory lipid mediators and affect epidermal lipid metabolism. Appropriate fatty acid balance may improve barrier integrity while reducing inflammatory signaling.
Clinical relevance: Lipid quality is generally more important than absolute fat concentration in food-responsive dermatosis (Kirby et al., 2007; Kar et al., 2024).
Ultra-Processed Diets and Dietary Complexity
Claim: Increasing dietary complexity may complicate identification of offending ingredients during elimination trials.
Mechanism: Diets containing numerous protein sources, flavorings, or ingredient substitutions increase the number of potential dietary antigens encountered by the immune system and make interpretation of elimination trials more difficult.
Clinical relevance: Controlled elimination diets emphasize consistent ingredient composition to improve diagnostic accuracy.
For broader discussion of dietary processing and current evidence, see Ultra-Processed vs Minimally Processed Pet Foods.
Evidence-Based Nutritional Strategies
Nutrition is central to both the diagnosis and long-term management of food-responsive dermatosis (FRD). Unlike pharmacologic therapies that primarily suppress inflammation, dietary interventions aim to remove the initiating antigen, restore epithelial barrier function, support immune regulation, and promote resolution of chronic inflammation. The quality of available evidence varies among nutrients, with elimination diets supported by strong clinical evidence and several functional nutritional approaches supported by emerging mechanistic research.
Fat
Claim: Dietary fat quality influences inflammatory signaling and epidermal barrier integrity in dogs with food-responsive dermatosis.
Mechanism: Long-chain polyunsaturated fatty acids regulate production of lipid-derived inflammatory mediators. Omega-6 fatty acids are precursors for prostaglandins and leukotrienes involved in inflammatory responses, whereas omega-3 fatty acids—including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—compete for the same enzymatic pathways, promoting the formation of less inflammatory eicosanoids and specialized pro-resolving mediators.
Dietary lipids also contribute structurally to the epidermal lipid matrix. Adequate lipid availability supports synthesis of ceramides and other barrier lipids that reduce transepidermal water loss and improve resistance to environmental irritants.
Clinical relevance: Fat quality influences both inflammation and skin barrier recovery. Although fatty acid supplementation does not replace elimination diets, optimizing lipid composition may reduce pruritus, improve skin hydration, and support recovery once dietary allergens have been removed.
Strong evidence: Multiple randomized veterinary clinical trials demonstrate that diets enriched with essential fatty acids improve dermatologic lesion scores and reduce pruritus in dogs with allergic skin disease, particularly when used alongside conventional management rather than as stand-alone therapy (Abbà et al., 2005; Bensignor et al., 2008; Saevik et al., 2004; Schäfer & Thom, 2024).
Emerging evidence: Research continues to investigate how dietary fatty acids influence skin lipid composition, epidermal ceramide production, and immune signaling beyond simple anti-inflammatory effects (Popa et al., 2011; Yoon et al., 2020; Kar et al., 2024).
Readers interested in inflammatory lipid biology may also explore:
Lipid Metabolism and Inflammation in Dogs
Protein
Claim: Protein selection is the most important nutritional decision in food-responsive dermatosis because dietary proteins represent the primary antigenic trigger.
Mechanism: Food-responsive dermatosis develops when immune recognition of specific dietary proteins results in chronic hypersensitivity. Nutritional strategies therefore aim to minimize immune exposure by either eliminating previously consumed protein sources (novel protein diets) or reducing antigenicity through enzymatic hydrolysis (hydrolyzed protein diets).
Hydrolyzed proteins consist of peptides sufficiently small to reduce recognition by immunoglobulins and T-cell receptors, thereby decreasing the likelihood of triggering hypersensitivity reactions during elimination trials.
Protein digestibility also influences antigen exposure. Highly digestible protein sources reduce the amount of undigested substrate reaching the colon, potentially decreasing dysbiosis, microbial fermentation, and secondary inflammatory signaling.
Clinical relevance: Successful elimination diet trials depend primarily on appropriate protein selection, strict dietary adherence, and avoidance of unintended antigen exposure from treats, flavored medications, supplements, or table foods.
Strong evidence: Elimination diets remain the accepted diagnostic gold standard for food-responsive dermatosis and cutaneous adverse food reactions. Both hydrolyzed and appropriately selected novel protein diets have demonstrated clinical effectiveness when fed exclusively during diagnostic trials (Olivry et al., 2010; Eisenschenk, 2024).
Emerging evidence: Recent studies suggest that dietary formulations supporting gut microbial diversity and immune regulation may further enhance clinical outcomes beyond antigen elimination alone (Guidi et al., 2021; Badri et al., 2024).
For additional discussion of dietary protein quality, digestibility, and formulation, see Protein Levels and Sources in Canine Diets.
Carbohydrates and Fiber
Claim: Carbohydrates are rarely primary allergens in dogs, but carbohydrate quality and dietary fiber influence gastrointestinal health, microbial ecology, and immune regulation.
Mechanism: Fermentable dietary fibers serve as substrates for beneficial intestinal microorganisms, promoting production of short-chain fatty acids (SCFAs) such as butyrate. SCFAs support epithelial integrity, strengthen tight junctions, reduce intestinal permeability, and promote differentiation of regulatory T cells that contribute to oral immune tolerance.
Highly refined carbohydrates, in contrast, generally provide limited fermentable substrate and may reduce microbial diversity when consumed within nutritionally imbalanced dietary patterns. The overall dietary matrix—including fiber composition—appears more important than carbohydrate quantity alone.
Clinical relevance: Maintaining gastrointestinal barrier integrity supports elimination diet success by limiting antigen translocation and reducing chronic immune stimulation. Fiber selection should therefore be considered within the broader context of digestive health rather than solely as a source of energy.
Emerging evidence: Growing evidence supports the contribution of microbiome-targeted nutrition to dermatologic health by modulating the gut–skin axis, although canine-specific intervention studies remain relatively limited (Badri et al., 2024; Grant et al., 2025; Lagoa et al., 2025).
Extrapolated evidence: Research on human food allergy and atopic dermatitis consistently demonstrates interactions among dietary fiber, microbial metabolites, and immune tolerance. Similar biological mechanisms are considered plausible in dogs but require further species-specific investigation.
Readers interested in gastrointestinal immune interactions may also refer to Gut Microbiome and Digestive Health.
Micronutrients
Claim: Micronutrients support epithelial integrity, antioxidant defense, immune regulation, and tissue repair but should be viewed as adjunctive nutritional factors rather than primary treatments for food-responsive dermatosis.
Zinc
Mechanism: Zinc functions as a cofactor for numerous enzymes involved in keratinocyte proliferation, epidermal differentiation, antioxidant defense, and both innate and adaptive immune responses. Deficiency impairs epithelial repair and weakens cutaneous barrier function.
Clinical relevance: Adequate zinc intake supports normal skin health, although supplementation beyond nutritional requirements has demonstrated variable benefit except in dogs with confirmed deficiency or specific zinc-responsive dermatoses.
Strong evidence: Zinc deficiency is a well-established cause of dermatologic disease in dogs, while adjunctive zinc supplementation has demonstrated modest benefit in selected inflammatory skin disorders (Thoday, 1989; McFadden et al., 2017).
Antioxidant Vitamins
Mechanism: Vitamins A and E contribute to epithelial maintenance by limiting oxidative injury, stabilizing cell membranes, and supporting keratinocyte differentiation.
Clinical relevance: Chronic inflammatory skin disease increases oxidative stress, supporting the rationale for maintaining adequate intake of antioxidant nutrients as part of balanced dietary management.
Emerging evidence: Functional diets containing multiple antioxidant nutrients have shown improvements in clinical dermatologic scoring, although the contributions of individual nutrients remain difficult to isolate (De Santiago et al., 2021; Marchegiani et al., 2020).
Combined Nutritional Formulations
Claim: Nutritional interventions targeting multiple biological pathways may provide greater clinical benefit than isolated nutrient supplementation.
Mechanism: Combined formulations simultaneously influence inflammatory signaling, epithelial lipid synthesis, oxidative stress, microbiome composition, and immune regulation. This multimodal approach reflects the multifactorial nature of food-responsive dermatosis.
Clinical relevance: Because FRD involves interacting gastrointestinal and dermatologic mechanisms, comprehensive dietary formulations may better support long-term management than single-nutrient interventions.
Emerging evidence: Recent clinical studies evaluating therapeutic diets enriched with combinations of fatty acids, antioxidants, microbiome-supporting ingredients, and functional nutrients have demonstrated improvements in pruritus scores, lesion severity, and owner-assessed quality of life (Witzel-Rollins et al., 2019; Boehm et al., 2021; Frizzo-Ramos et al., 2025).
Clinical Perspective
Current evidence indicates that dietary protein selection remains the foundation of nutritional management for food-responsive dermatosis because removal of the offending antigen directly addresses disease pathophysiology. Optimization of dietary fat quality, microbiome-supportive nutrition, and micronutrient adequacy appears to complement elimination diets by improving barrier function and immune regulation rather than replacing diagnostic dietary intervention.
Overall, the evidence supports a hierarchical nutritional approach:
-
Strong evidence: Elimination diets using hydrolyzed or appropriate novel proteins; optimized essential fatty acid intake as an adjunct to dietary management.
-
Emerging evidence: Microbiome-targeted nutrition, postbiotics, combined functional dietary formulations, and multimodal nutritional strategies.
-
Extrapolated evidence: Precision micronutrient modulation and individualized immunonutrition based on mechanistic studies and translational dermatology research.
Functional Ingredients in Food-Responsive Dermatosis
While elimination of dietary allergens remains the primary nutritional intervention for food-responsive dermatosis (FRD), growing evidence suggests that selected functional ingredients may support skin barrier repair, immune regulation, and restoration of the gut–skin axis. These ingredients should be viewed as adjunctive nutritional strategies rather than substitutes for properly conducted elimination diet trials.
Essential Fatty Acids
Mechanism: Essential fatty acids (EFAs), particularly long-chain omega-3 fatty acids, influence inflammatory signaling by altering eicosanoid synthesis, promoting the production of specialized pro-resolving lipid mediators, and supporting epidermal lipid organization. They also contribute to maintenance of the stratum corneum and reduction of transepidermal water loss.
Clinical relevance: In dogs with food-responsive dermatosis, EFAs may reduce the intensity of secondary inflammation after dietary antigen removal and support recovery of the impaired skin barrier. Improvements are generally gradual and are most consistently observed when fatty acid optimization is incorporated into a complete nutritional management plan.
Evidence classification: Strong evidence for adjunctive use in inflammatory skin disease; emerging evidence for effects on epidermal lipid remodeling and immune regulation.
See Essential Fatty Acids and Skin Health in Dogs: Mechanisms Beyond Omega-3.
Zinc
Mechanism: Zinc participates in numerous enzymatic pathways that regulate keratinocyte proliferation, epithelial differentiation, antioxidant defenses, and both innate and adaptive immune functions. Adequate zinc availability supports epidermal turnover and wound healing while helping maintain barrier integrity.
Clinical relevance: Although zinc deficiency is uncommon in dogs consuming nutritionally complete diets, marginal zinc status may impair epithelial repair in chronic inflammatory skin disease. Zinc is therefore considered supportive of barrier recovery rather than a primary treatment for food-responsive dermatosis.
Evidence classification: Strong evidence for zinc-responsive dermatoses; emerging evidence for adjunctive use in inflammatory skin disease.
See Zinc in Canine Nutrition: Gut, Skin, and Immune Function.
Ceramides
Mechanism: Ceramides are major structural lipids within the stratum corneum that regulate epidermal permeability and water retention. Chronic inflammation alters ceramide metabolism, weakening the skin barrier and facilitating penetration of allergens and microorganisms.
Nutritional strategies that support endogenous ceramide synthesis may complement elimination diets by promoting restoration of epidermal barrier function.
Clinical relevance: Barrier repair becomes increasingly important after dietary allergens have been eliminated, particularly in dogs with chronic or recurrent skin disease in which inflammation has produced persistent structural abnormalities.
Evidence classification: Emerging evidence, supported by mechanistic and translational studies evaluating epidermal lipid metabolism.
See Ceramides and Skin Barrier Lipids in Dogs: Nutritional Implication.
Postbiotics
Mechanism: Postbiotics are bioactive microbial metabolites produced during bacterial fermentation. These compounds influence epithelial integrity, immune tolerance, inflammatory signaling, and communication along the gut–skin axis without requiring administration of live microorganisms.
Recent studies suggest that postbiotics may influence cytokine production, regulatory T-cell activity, microbial diversity, and production of beneficial metabolites that strengthen intestinal barrier function.
Clinical relevance: Because food-responsive dermatosis involves disruption of both gastrointestinal and cutaneous immune homeostasis, postbiotics represent a promising adjunctive nutritional strategy for supporting long-term disease control following successful elimination diets.
Evidence classification: Emerging evidence supported by systematic reviews and randomized clinical trials, although optimal formulations and long-term clinical applications continue to be investigated (Bonel-Ayuso et al., 2025; Grant et al., 2025; Sordillo et al., 2025).
See Postbiotics and Skin Health in Dogs: Microbiome-Derived Compounds and Clinical Implications.
Collectively, these functional ingredients target complementary biological pathways involved in food-responsive dermatosis—including inflammation, epithelial repair, lipid metabolism, antioxidant defense, and gut microbial homeostasis. Their greatest value is likely achieved when incorporated into comprehensive nutritional strategies centered on accurate identification and elimination of dietary allergens rather than as isolated interventions.
Dietary Approaches
Therapeutic Elimination Diets
Claim: Therapeutic elimination diets remain the cornerstone of nutritional diagnosis and management for food-responsive dermatosis.
Mechanism: Elimination diets remove dietary proteins that can stimulate immune responses while providing nutritionally complete alternatives that support normal metabolic function. Depending on the clinical situation, elimination diets may utilize hydrolyzed proteins or carefully selected novel protein sources to minimize antigen recognition.
Strict adherence is essential because even small quantities of previously consumed proteins from treats, flavored medications, supplements, or table foods may reintroduce dietary antigens and compromise diagnostic accuracy.
Clinical relevance: Clinical improvement during elimination feeding followed by recurrence after dietary challenge remains the accepted diagnostic standard for confirming food-responsive dermatosis. Consequently, nutritional therapy serves both diagnostic and therapeutic purposes.
Strong evidence: International dermatology guidelines consistently recognize elimination diets as the reference standard for diagnosis of cutaneous adverse food reactions (Olivry et al., 2010; Eisenschenk, 2024).
Fresh Versus More Processed Diets
Claim: Current evidence does not support selecting diets solely according to their degree of processing when managing food-responsive dermatosis.
Mechanism: Diet processing influences nutrient stability, digestibility, palatability, and ingredient composition; however, the immunologic response in food-responsive dermatosis is directed primarily against dietary antigens rather than the processing method itself.
Fresh diets formulated as nutritionally complete elimination diets may improve acceptance in some dogs and provide highly digestible nutrients. Conversely, appropriately formulated therapeutic processed diets also demonstrate excellent clinical effectiveness when dietary antigen exposure is adequately controlled.
Clinical relevance: Selection between fresh and processed diets should therefore focus on:
-
Appropriate protein selection
-
Nutritional completeness
-
Consistent formulation
-
Owner compliance
-
Diagnostic reliability
rather than assumptions regarding processing alone.
For additional discussion, see the VetFarmacy Evidence Library pages:
Fresh Diets in Dogs and Ultra-Processed vs Minimally Processed Pet Foods
Emerging evidence: Preliminary studies suggest that diet composition and microbiome effects may influence long-term dermatologic outcomes, but evidence remains insufficient to conclude that fresh diets are inherently superior for food-responsive dermatosis (Maina & Cox, 2025; Badri et al., 2024).
VetFarmacy Clinical Resource
Readers seeking a structured approach to nutritional management of suspected food-responsive dermatosis can access the VetFarmacy clinical guide:
Veterinary Diet Decision Framework for Dogs
This evidence-based clinical reference explains how veterinarians evaluate diet strategies for suspected food-responsive dermatosis and other nutrition-responsive diseases. It outlines how dietary protein selection, elimination diet trials, ingredient digestibility, fat composition, and gut microbiome support influence clinical decision-making and long-term nutritional management.
The framework includes practical guidance for:
-
Selecting appropriate elimination diet strategies
-
Understanding when hydrolyzed versus novel protein diets are indicated
-
Evaluating microbiome-supportive nutritional approaches during elimination trials
Subscribers gain access to structured clinical tools that translate veterinary nutrition evidence into practical dietary decision-making.
Clinical Outcomes and Evidence Summary
Nutritional management of food-responsive dermatosis aims to achieve more than reduction of pruritus. Successful dietary intervention addresses the initiating antigen while supporting restoration of immune tolerance, intestinal barrier integrity, epidermal lipid metabolism, and long-term skin health.
Clinical outcomes are typically evaluated using combinations of:
-
Pruritus scoring
-
Dermatologic lesion indices
-
Frequency of secondary skin infections
-
Recurrence following dietary challenge
-
Quality-of-life assessments
-
Medication requirements
-
Gastrointestinal clinical signs
-
Emerging biomarkers of inflammation and microbiome composition
Because food-responsive dermatosis is fundamentally an immune-mediated disease triggered by dietary exposure, sustained improvement generally depends on continued avoidance of confirmed dietary allergens rather than temporary suppression of inflammation.
Strong Evidence
Current veterinary evidence consistently supports:
-
Elimination diets as the diagnostic gold standard for food-responsive dermatosis.
-
Hydrolyzed and appropriately selected novel protein diets during elimination trials.
-
Essential fatty acids as adjunctive nutritional support for inflammatory skin disease.
-
Strict dietary compliance throughout elimination and dietary challenge phases.
-
Nutritionally complete therapeutic diets for long-term management following diagnosis.
For broader discussion of inflammatory mechanisms, see Inflammation and Nutritional Modulation.
Emerging Evidence
Growing evidence supports investigation of:
-
Gut microbiome modulation
-
Postbiotic supplementation
-
Multimodal nutritional formulations
-
Skin barrier lipid restoration
-
Precision nutritional strategies targeting immune regulation
Recent randomized clinical trials and systematic reviews suggest these interventions may improve dermatologic outcomes, although larger controlled veterinary studies remain necessary before routine clinical recommendations can be established (Bonel-Ayuso et al., 2025; Frizzo-Ramos et al., 2025; Grant et al., 2025).
Extrapolated Evidence
Several promising nutritional concepts currently rely primarily on mechanistic or translational research, including:
-
Precision immunonutrition
-
Targeted modulation of regulatory T-cell function
-
Individualized microbiome-directed nutrition
-
Nutritional optimization of epidermal ceramide synthesis
-
Novel postbiotic metabolites influencing immune tolerance
Although biologically plausible, these approaches require additional canine-specific clinical trials before they can be incorporated into evidence-based nutritional guidelines.
Readers interested in evaluating the quality and limitations of veterinary nutrition research may also refer to Limitations of Veterinary Clinical Trials.
Overall, current evidence indicates that nutritional management of food-responsive dermatosis should prioritize elimination of dietary allergens while integrating supportive nutritional strategies that enhance barrier repair, immune regulation, and gastrointestinal health. Continued advances in microbiome science and functional nutrition are expected to refine future dietary approaches, but elimination diets remain the foundation against which emerging nutritional interventions should be evaluated.
Clinical Decision Support
Nutritional management of food-responsive dermatosis requires integrating clinical history, dietary exposure, dermatologic findings, gastrointestinal signs, and responses to structured dietary trials. Because no single laboratory test definitively confirms food-responsive dermatosis in most dogs, clinical decision-making relies heavily on nutritional assessment and careful interpretation of elimination diet outcomes.
The following considerations help guide evidence-based dietary decision-making:
-
Presence of non-seasonal pruritus, recurrent otitis externa, or recurrent superficial pyoderma.
-
Concurrent gastrointestinal signs, including chronic diarrhea, vomiting, flatulence, or increased stool frequency.
-
Previous dietary history, including protein sources and prior elimination diet attempts.
-
Degree of clinical improvement during exclusive elimination feeding.
-
Recurrence of clinical signs following dietary provocation.
-
Presence of concurrent allergic diseases such as canine atopic dermatitis, which may coexist with food-responsive dermatosis.
Successful management also requires recognition that improvement may occur gradually as both intestinal and epidermal barrier function recover. Nutritional interventions should therefore be evaluated over an appropriate diagnostic timeframe before conclusions regarding efficacy are made.
Clinical application
Nutrition should be individualized based on disease mechanisms rather than on clinical signs alone.
-
Dogs with suspected dietary hypersensitivity should undergo a structured elimination diet trial before long-term nutritional recommendations are made.
-
Dogs with mixed allergic disease may require nutritional management alongside environmental allergy control.
-
Persistent dermatologic disease despite appropriate elimination trials should prompt reassessment of diagnosis, dietary compliance, concurrent infections, ectoparasites, or additional allergic conditions.
For a structured framework that compares dietary approaches according to disease mechanisms and clinical presentation, see: Compare diet strategies for this condition (Anti-Inflammatory and Elimination Diet Strategies for Skin Disease: Clinical Framework)
What to Feed: Translating Evidence Into Practice
Diet selection should be guided by the underlying disease mechanisms, clinical severity, and individual response to previous dietary interventions. The options below summarize how different dietary strategies are typically applied in clinical practice.
Hydrolyzed Diets
Use when:
-
Chronic or unexplained pruritus persists.
-
Cutaneous adverse food reactions are suspected.
-
A diagnostic elimination diet trial is indicated.
-
Previous dietary history includes multiple exposures to protein.
Clinical rationale
Hydrolyzed diets reduce exposure to intact dietary proteins by providing peptides that are less likely to trigger immune recognition. They are widely used during elimination diet trials and remain one of the primary nutritional approaches for diagnosing food-responsive dermatosis.
Compare hydrolyzed diet options for this condition (Hydrolyzed Diets for Dogs with Food-Responsive Dermatosis)
Fresh / Minimally Processed Diets
Use when:
-
Long-term nutritional management is required following diagnosis.
-
Dietary acceptance or owner compliance is a concern.
-
A nutritionally complete limited-ingredient formulation is appropriate.
Clinical rationale
Fresh diets may improve palatability and provide highly digestible nutrients depending on formulation. Their potential benefits in food-responsive dermatosis primarily lie in appropriate ingredient selection and nutritional completeness, rather than in reduced processing alone.
Explore fresh diet options for this condition (Fresh Diets for Dogs with Food-Responsive Dermatosis)
How to Choose Between These Options
-
For acute or severe presentations, more controlled therapeutic elimination diets are typically preferred because they provide greater confidence during diagnostic evaluation.
-
For chronic or unresolved cases, structured elimination-diet trials followed by a dietary challenge are generally necessary to confirm or exclude food-responsive disease.
-
For stable conditions requiring long-term management, diet selection depends on confirmed dietary triggers, nutritional adequacy, individual tolerance, clinical response, and owner practicality.
Diet selection is often iterative and may require adjustment based on clinical response.
Compare Diet Strategies for Food-Responsive Dermatosis
Explore structured diet options based on clinical use:
-
Compare hydrolyzed diets
-
Explore fresh diet options
Key Takeaways
Cutaneous adverse food reaction (CAFR): An immune-mediated reaction to dietary components that manifests primarily as dermatologic disease.
Food-responsive dermatosis (FRD): A clinical syndrome in which skin disease improves following elimination of dietary allergens and recurs after dietary challenge.
Elimination diet: A controlled dietary trial using hydrolyzed or novel proteins to identify food-related hypersensitivity.
Hydrolyzed protein: Dietary protein enzymatically broken into smaller peptides to reduce immune recognition during elimination trials.
Novel protein: A protein source to which the dog has had little or no previous dietary exposure.
Gut–skin axis: Bidirectional communication between gastrointestinal health, the intestinal microbiome, immune regulation, and skin homeostasis.
Oral tolerance: Normal immune unresponsiveness toward dietary antigens that prevents inappropriate hypersensitivity reactions.
Skin barrier: The epidermal structure composed of keratinocytes and intercellular lipids that protects against allergen penetration and water loss.
Essential fatty acids: Polyunsaturated fatty acids involved in epidermal barrier maintenance and regulation of inflammatory lipid mediators.
Postbiotics: Bioactive microbial metabolites that influence epithelial integrity, immune regulation, and gut microbial function.
Evidence Notes
Strength of Evidence
Strong evidence
-
Elimination diets remain the diagnostic gold standard for food-responsive dermatosis.
-
Hydrolyzed and appropriately selected novel protein diets are effective diagnostic nutritional strategies.
-
Essential fatty acids provide clinically meaningful adjunctive support for inflammatory skin disease.
-
Long-term avoidance of confirmed dietary allergens reduces recurrence of clinical signs.
Emerging evidence
-
Gut microbiome modulation.
-
Postbiotic supplementation.
-
Multimodal functional nutritional formulations.
-
Nutritional support of epidermal barrier repair.
-
Precision nutrition targeting immune regulation.
Extrapolated evidence
-
Mechanistic studies examining ceramide metabolism and skin barrier lipids.
-
Human food allergy and dermatology research informing gut–skin interactions.
-
Experimental immunometabolic approaches targeting inflammatory signaling.
Research Gaps
Current knowledge is limited by:
-
Relatively few large multicenter randomized clinical trials.
-
Variable elimination diet protocols among published studies.
-
Limited long-term outcome data following nutritional intervention.
-
Incomplete understanding of interactions between nutrition, the microbiome, and immune tolerance.
-
Limited evidence regarding individualized precision nutrition for canine food-responsive dermatosis.
Translational Limitations
Many mechanistic concepts discussed in canine dermatology originate from human allergy research or experimental models. While these findings provide biologically plausible explanations for immune regulation, barrier function, and microbiome interactions, their direct application to canine patients should be interpreted with caution until supported by additional veterinary clinical evidence.
Readers interested in critical appraisal of nutrition research may also find the following VetFarmacy Evidence Library resource helpful: Limitations of Veterinary Clinical Trials
Compare Diet Strategies for Food-Responsive Dermatosis
Selecting the appropriate diet depends on disease severity, underlying mechanisms, and clinical response.
Explore structured decision pathways: Compare diet strategies for this condition (Anti-Inflammatory and Elimination Diet Strategies for Skin Disease: Clinical Framework)
VetFarmacy Clinical Resource
Food-responsive dermatosis requires systematic dietary assessment, careful elimination diet planning, and ongoing monitoring of clinical response. VetFarmacy provides downloadable clinical frameworks that translate current evidence into structured nutrition decision pathways.
Veterinary Diet Decision Framework for Dogs
The framework explains how veterinarians match dietary strategies to suspected food-responsive skin disease, including:
-
Identification of adverse food reactions through elimination diet trials
-
Selection of hydrolyzed and novel protein approaches based on clinical objectives
-
Integration of gastrointestinal health, microbiome function, and skin barrier support into long-term nutritional management
It also describes how dietary trials are initiated, monitored, interpreted, and adjusted in clinical practice, while minimizing diagnostic errors due to inconsistent feeding or unintended allergen exposure.
Subscribers receive access to current and future VetFarmacy clinical resources as new veterinary nutrition evidence becomes available.
References
-
Abbà, C., Mussa, P., Vercelli, A., & Raviri, G. (2005). Essential fatty acids supplementation in different-stage atopic dogs fed on a controlled diet. Journal of Animal Physiology and Animal Nutrition, 89(3–6), 203–207. https://doi.org/10.1111/j.1439-0396.2005.00541.x
-
Badri, D., & Panickar, K. (2022). Dietary intervention alleviates signs of atopic dermatitis in dogs by improving gut, skin and systemic immunity. Current Developments in Nutrition, 6(Supplement 1), 462. https://doi.org/10.1093/cdn/nzac058.001
-
Badri, D., Panickar, K., & Tavener, S. K. (2024). Nutritional intervention alleviates signs of dermatological problems in dogs by modulating immune regulation and skin microbiome. Current Developments in Nutrition. https://doi.org/10.1016/j.cdnut.2024.103452
-
Bensignor, E., Morgan, D. M., & Nuttall, T. (2008). Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: A randomized, single-blinded, cross-over study. Veterinary Dermatology, 19(3), 156–162. https://doi.org/10.1111/j.1365-3164.2008.00670.x
-
Blašković, M., Rosenkrantz, W., Neuber, A., Sauter-Louis, C., & Mueller, R. S. (2013). The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis. The Veterinary Journal, 199(1), 39–43. https://doi.org/10.1016/j.tvjl.2013.10.024
-
Boehm, T., Klinger, C., Udraite-Vovk, L., Navarro, C., & Mueller, R. S. (2021). Clinical effects of two commercially available diets on canine atopic dermatitis. Tierärztliche Praxis Kleintiere, 49(4), 256–261. https://doi.org/10.1055/a-1543-4743
-
Bonel-Ayuso, D. P., Pineda-Pampliega, J., García, P. M.-A., Fernández-Muela, M., De La Fuente, J., Fernandez, P. M. G., & Redondo, B. I. (2025). Effects of postbiotic administration on canine health: A systematic review and meta-analysis. Microorganisms, 13(7). https://doi.org/10.3390/microorganisms13071572
-
Cerrato, S., Ramió-Lluch, L., Fondevila, D., Rodes, D., Brazis, P., & Puigdemont, A. (2013). Effects of essential oils and polyunsaturated fatty acids on canine skin equivalents: Skin lipid assessment and morphological evaluation. Journal of Veterinary Medicine, 2013, Article 231526. https://doi.org/10.1155/2013/231526
-
De Santiago, M. S., Arribas, J. L., Llamas, Y. M., Bečvářová, I., & Meyer, H. (2021). Randomized, double-blind, placebo-controlled clinical trial measuring the effect of a dietetic food on dermatologic scoring and pruritus in dogs with atopic dermatitis. BMC Veterinary Research, 17, Article 357. https://doi.org/10.1186/s12917-021-03063-w
-
Eisenschenk, M. N. C. (2024). The role of diet, nutrition, and supplements in canine atopic dermatitis. Veterinary Clinics of North America: Small Animal Practice. https://doi.org/10.1016/j.cvsm.2024.11.003
-
Frizzo-Ramos, C., Doulidis, P. G., Burgener, I. A., Ungerböck, C. H., Einspieler, V., Weiser, U., Panakova, L., & Roth-Walter, F. (2025). Lymph food to improve canine atopic dermatitis: A randomized, double-blinded, controlled trial in dogs with standard-care treatment. Frontiers in Veterinary Science, 12. https://doi.org/10.3389/fvets.2025.1657869
-
Grant, L., Dehcheshmeh, M. M., Ebrahimie, E., Khabiri, A., Veltman, T., Shipstone, M., & Trott, D. J. (2025). The effect of daily oral probiotic and postbiotic supplementation on the canine skin microbiota: Insights from culture-dependent and long-read 16S rRNA gene sequencing methods. Veterinary Dermatology. Advance online publication. https://doi.org/10.1111/vde.13353
-
Groves, E. (2022). CPD article: Diet in canine dermatology part 1: Nutrition for skin health and support. The Veterinary Nurse, 13(6), 262–267. https://doi.org/10.12968/vetn.2022.13.6.262
-
Guidi, E., Gramenzi, A., Persico, P., Di Prinzio, R., Di Simone, D., & Cornegliani, L. (2021). Effects of feeding a hypoallergenic diet with a nutraceutical on fecal dysbiosis index and clinical manifestations of canine atopic dermatitis. Animals, 11(10), 2985. https://doi.org/10.3390/ani11102985
-
Jaffey, J., Backus, R., Sprinkle, M., Ruggiero, C., Ferguson, S. H., & Shumway, K. L. (2020). Successful long-term management of canine superficial necrolytic dermatitis with amino acid infusions and nutritionally balanced home-made diet modification. Frontiers in Veterinary Science, 7, Article 28. https://doi.org/10.3389/fvets.2020.00028
-
Kar, P., Rajesh, J. B., Behera, S. K., Konwar, B., Samanta, A., Prasad, H., Sarma, K., & Tolenkhomba, T. (2024). Omega fatty acids and its role in amelioration of canine dermatological disorders. Journal of Scientific Research and Reports, 30(11). https://doi.org/10.9734/jsrr/2024/v30i112618
-
Kirby, N. A., Hester, S. L., & Bauer, J. E. (2007). Dietary fats and the skin and coat of dogs. Journal of the American Veterinary Medical Association, 230(11), 1641–1644. https://doi.org/10.2460/javma.230.11.1641
-
Lagoa, T., Martins, L., & Queiroga, M. C. (2025). Microbiota modulation as an approach to prevent the use of antimicrobials associated with canine atopic dermatitis. Biomedicines, 13(10). https://doi.org/10.3390/biomedicines13102372
-
Loftus, J., Miller, A. J., Center, S. A., Peters-Kennedy, J., & Astor, M. (2022). Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy. Journal of Veterinary Internal Medicine, 36(1), 106–115. https://doi.org/10.1111/jvim.16323
-
Maina, E., & Cox, E. (2025). Exploring the potential link between vegetable oil supplementation and adverse food reactions in dogs: A preliminary study. BMC Veterinary Research, 21. https://doi.org/10.1186/s12917-025-04720-0
-
Marchegiani, A., Fruganti, A., Spaterna, A., Della Vedova, E., Bachetti, B., Massimini, M., Di Pierro, F., Gavazza, A., & Cerquetella, M. (2020). Impact of nutritional supplementation on canine dermatological disorders. Veterinary Sciences, 7(2), 38. https://doi.org/10.3390/vetsci7020038
-
Marsella, R. (2013). Fixing the skin barrier: Past, present and future—Man and dog compared. Veterinary Dermatology, 24(1), 73–76.e17–18. https://doi.org/10.1111/j.1365-3164.2012.01073.x
-
Marsella, R., Cornegliani, L., Ozmen, I., Bohannon, M., Ahrens, K., & Santoro, D. (2017). Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis. Veterinary Dermatology, 28(6), 577–e140. https://doi.org/10.1111/vde.12467
-
Marsella, R., Segarra, S., Ahrens, K., Alonso, C., & Ferrer, L. (2020). Topical treatment with sphingolipids and glycosaminoglycans for canine atopic dermatitis. BMC Veterinary Research, 16, Article 92. https://doi.org/10.1186/s12917-020-02306-6
-
Martinez, N., & McDonald, B. (2021). A study into the fatty acid content of selected veterinary diets, supplements and fish oil capsules in Australia. Veterinary Dermatology. Advance online publication. https://doi.org/10.1111/vde.12950
-
McFadden, R. A., Heinrich, N. A., Haarstad, A. C., & Tomlinson, D. (2017). A double-blinded, randomized, controlled, crossover evaluation of a zinc methionine supplement as an adjunctive treatment for canine atopic dermatitis. Veterinary Dermatology, 28(6), 569–e138. https://doi.org/10.1111/vde.12466
-
Olivry, T., DeBoer, D. J., Favrot, C., Jackson, H. A., Mueller, R. S., Nuttall, T., & Prélaud, P. (2010). Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology, 21(3), 233–248. https://doi.org/10.1111/j.1365-3164.2010.00889.x
-
Olivry, T., Marsella, R., & Hillier, A. (2001). The ACVD task force on canine atopic dermatitis (XXIII): Are essential fatty acids effective? Veterinary Immunology and Immunopathology, 81(3–4), 347–362. https://doi.org/10.1016/S0165-2427(01)00316-6
-
Padmanabhan, N., & Krishnamoorthy, G. (2017). Therapeutic relevance of dietary ratio of polyunsaturated fatty acids N-6:N-3 in canine atopic dermatitis.
-
Park, M., Hong, J., Cho, W., & Song, K. (2025). Clinical evaluation of a functional diet containing Siraitia grosvenorii residual extract for atopic dermatitis in dogs: A self-controlled study. BMC Veterinary Research, 21. https://doi.org/10.1186/s12917-025-05055-6
-
Popa, I., Pin, D., Remoué, N., Osta, B., Callejon, S., Vidémont, E., Gatto, H., Portoukalian, J., & Haftek, M. (2011). Analysis of epidermal lipids in normal and atopic dogs before and after administration of an oral omega-6/omega-3 fatty acid feed supplement: A pilot study. Veterinary Research Communications, 35(8), 501–509. https://doi.org/10.1007/s11259-011-9493-7
-
Prescott, D., Stewart, A., Schoep, A., & Herndon, A. (2025). Topical cream with essential oils, zinc and salicylic acid reduces pruritus and skin lesion scores in pruritic dogs. Australian Veterinary Journal, 104, 196–205. https://doi.org/10.1111/avj.70048
-
Saevik, B. K., Bergvall, K., Holm, B., Saijonmaa-Koulumies, L., Hedhammar, Å., Larsen, S., & Kristensen, F. (2004). A randomized, controlled study to evaluate the steroid-sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Veterinary Dermatology, 15(3), 137–145. https://doi.org/10.1111/j.1365-3164.2004.00378.x
-
Saika, A., Nagatake, T., Kishino, S., Kitamura, N., Honda, T., Hosomi, K., Tiwari, P., Node, E., Kawai, S., Kondo, S., Ishida, K., Kabashima, K., Ogawa, J., & Kunisawa, J. (2024). The omega-3 postbiotic trans-10-cis-15-octadecadienoic acid attenuates contact hypersensitivity in mice through downregulation of vascular endothelial growth factor A. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1355679
-
Schäfer, L., & Thom, N. (2024). A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs. Veterinary Dermatology. Advance online publication. https://doi.org/10.1111/vde.13246
-
Schumann, J., Basiouni, S., Basiouni, S., Gück, T., & Fuhrmann, H. (2014). Treating canine atopic dermatitis with unsaturated fatty acids: The role of mast cells and potential mechanisms of action. Journal of Animal Physiology and Animal Nutrition, 98(6), 1013–1020. https://doi.org/10.1111/jpn.12181
-
Sordillo, A., Heldrich, J., Turcotte, R., & Sheth, R. U. (2025). An indole-rich postbiotic reduces itching in dogs: A randomized, double-blinded placebo-controlled study. Animals, 15(14). https://doi.org/10.3390/ani15142019
-
Thoday, K. L. (1989). Diet-related zinc-responsive skin disease in dogs: A dying dermatosis? Journal of Small Animal Practice, 30(4), 213–215. https://doi.org/10.1111/j.1748-5827.1989.tb01539.x
-
Tretter, S., & Mueller, R. S. (2011). The influence of topical unsaturated fatty acids and essential oils on normal and atopic dogs. Journal of the American Animal Hospital Association, 47(4), 236–240. https://doi.org/10.5326/JAAHA-MS-5607
-
Van Amersfort, K., Van der Lee, A., & Hagen-Plantinga, E. (2023). Evidence-base for the beneficial effect of nutraceuticals in canine dermatological immune-mediated inflammatory diseases: A literature review. Veterinary Dermatology. Advance online publication. https://doi.org/10.1111/vde.13152
-
Watson, T. D. G. (1998). Diet and skin disease in dogs and cats. The Journal of Nutrition, 128(12 Suppl.), 2783S–2789S. https://doi.org/10.1093/jn/128.12.2783S
-
Witzel-Rollins, A., Murphy, M., Bečvářová, I., Werre, S. R., Cadiergues, M. C., & Meyer, H. (2019). Non-controlled, open-label clinical trial to assess the effectiveness of a dietetic food on pruritus and dermatologic scoring in atopic dogs. BMC Veterinary Research, 15, Article 220. https://doi.org/10.1186/s12917-019-1929-2
-
Yoon, J.-S., Nishifuji, K., & Iwasaki, T. (2020). Supplementation with eicosapentaenoic acid and linoleic acid increases the production of epidermal ceramides in in vitro canine keratinocytes. Veterinary Dermatology, 31(6). https://doi.org/10.1111/vde.12881
-
Zablah, A. C., & Lio, P. A. (2025). Oral lipids/fatty acid supplements and eczema: What is known? Dermatitis, 37, 55–60. https://doi.org/10.1089/derm.2024.0317